NSCLC Microenvironment Subtypes Correlate with Response and Survival to Immune Checkpoint Inhibitor Therapy

被引：0
|
作者：
Danilov, K. [1 ]
Bansal, D. [2 ]
Ward, C. [2 ]
Al-Obaidi, A. [3 ]
Pluard, T. [2 ]
Tarasov, A. [1 ]
Valiev, I. [1 ]
Kushnarev, V. [1 ]
Makarova, A. [1 ]
Butusova, A. [1 ]
Love, A. [1 ]
Nomie, K. [1 ]
Bagaev, A. [1 ]
Subramanian, J. [4 ]
Fowler, N. [1 ]
机构：
[1] BostonGene Corp, Waltham, MA USA
[2] St Lukes Canc Inst, Kansas City, MO USA
[3] Univ Missouri Kansas City, Kansas City, MO USA
[4] Inova Schar Canc Inst, Fairfax, VA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Tumor microenvironment; Immune checkpoint inhibitors; Molecular subtypes;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.21-16
引用
收藏
页码：S241 / S241
页数：1
相关论文
共 50 条
  • [1] Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy
    Subramanian, Madhav
    Ul Kabir, Ashraf
    Barisas, Derek
    Krchma, Karen
    Choi, Kyunghee
    CELL REPORTS MEDICINE, 2023, 4 (01)
  • [2] Microenvironment Is a Key Determinant of Immune Checkpoint Inhibitor Response
    Cho, Shih-Feng
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    CLINICAL CANCER RESEARCH, 2022, 28 (08) : 1479 - 1481
  • [3] Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
    Suresh, Karthik
    Psoter, Kevin J.
    Voong, Khinh Ranh
    Shankar, Bairavi
    Forde, Patrick M.
    Ettinger, David S.
    Marrone, Kristen A.
    Kelly, Ronan J.
    Hann, Christine L.
    Levy, Benjamin
    Feliciano, Josephine L.
    Brahmer, Julie R.
    Feller-Kopman, David
    Lerner, Andrew D.
    Lee, Hans
    Yarmus, Lonny
    Hales, Russell K.
    D'Alessio, Franco
    Danoff, Sonye K.
    Naidoo, Jarushka
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : 494 - 502
  • [4] Clinically relevant prognostic biomarkers for immune checkpoint inhibitor therapy in NSCLC
    Zeitler, Gloria
    Brueckl, Wolfgang
    Ficker, Joachim
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 16 - 16
  • [5] Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability
    Tostes, Katiane
    Siqueira, Alexia Polo
    Reis, Rui Manuel
    Leal, Leticia Ferro
    Arantes, Lidia Maria Rebolho Batista
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [6] Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma
    Vos, Joris L.
    Traets, Joleen J. H.
    Qiao, Xiaohang
    Seignette, Iris M.
    Peters, Dennis
    Wouters, Michel W. J. M.
    Hooijberg, Erik
    Broeks, Annegien
    van der Wal, Jacqueline E.
    Karakullukcu, M. Baris
    Klop, W. Martin C.
    Navran, Arash
    van Beurden, Marc
    Brouwer, Oscar R.
    Morris, Luc G. T.
    van Poelgeest, Mariette I. E.
    Kapiteijn, Ellen
    Haanen, John B. A. G.
    Blank, Christian U.
    Zuur, Charlotte L.
    JCI INSIGHT, 2024, 9 (21)
  • [7] An Algorithm as a Biomarker for Response to Immune Checkpoint Inhibitor Therapy
    Rimm, David L.
    JAMA ONCOLOGY, 2023, 9 (01) : 60 - 61
  • [8] Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
    Pinato, David J.
    Howlett, Sarah
    Ottaviani, Diego
    Urus, Heather
    Patel, Aisha
    Mineo, Takashi
    Brock, Cathryn
    Power, Danielle
    Hatcher, Olivia
    Falconer, Alison
    Ingle, Manasi
    Brown, Anna
    Gujral, Dorothy
    Partridge, Sarah
    Sarwar, Naveed
    Gonzalez, Michael
    Bendle, Maggie
    Lewanski, Conrad
    Newsom-Davis, Thomas
    Allara, Elias
    Bower, Mark
    JAMA ONCOLOGY, 2019, 5 (12) : 1774 - 1778
  • [9] The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC
    Li, Xiaohua
    Wang, Yuntao
    Li, Xuebing
    Feng, Gang
    Hu, Sheng
    Bai, Yifeng
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
    Min Hwan Kim
    Jae-Hwan Kim
    Ji Min Lee
    Jae Woo Choi
    Dongmin Jung
    Hojin Cho
    Hyundeok Kang
    Min Hee Hong
    Su Jin Heo
    Se Heon Kim
    Eun Chang Choi
    Da Hee Kim
    Young Min Park
    Sangwoo Kim
    Sun Och Yoon
    Yoon Woo Koh
    Byoung Chul Cho
    Hye Ryun Kim
    British Journal of Cancer, 2020, 122 : 1649 - 1660
12345